BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38537994)

  • 21. [Adjuvant and perioperative neoadjuvant therapy for colorectal cancer].
    Liu FQ; Cai SJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):315-320. PubMed ID: 31054544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis.
    Chen JH; Ye Q; Huang F
    BMC Gastroenterol; 2023 Mar; 23(1):83. PubMed ID: 36959560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
    Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
    Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
    BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
    Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
    Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
    Marolleau P; Tougeron D; Allignet B; Cohen R; Sefrioui D; Gallet B; Dumont F; Guimbaud R; Alouani E; Passot G; Desolneux G; Ghiringhelli F; Marchal F; Mourthadhoi F; Coriat R; Desgrippes R; Locher C; Goujon G; Des Guetz G; Aparicio T; Paubelle E; Dupré A; de la Fouchardière C
    Int J Cancer; 2023 Oct; 153(7):1376-1385. PubMed ID: 37403609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver.
    Baidoun F; Merjaneh Z; Nanah R; Saad AM; Abdel-Rahman O
    J Comp Eff Res; 2022 Sep; 11(13):935-951. PubMed ID: 35787069
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prognostic analysis of different comprehensive treatment models for locally advanced esophageal squamous cell carcinoma based on propensity score matching].
    Wang YC; Liu JF; Lu H; Zhang XR; Sun XS
    Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):79-83. PubMed ID: 34954951
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J; Thephamongkhol K
    BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
    Kamarajah SK; White SA; Naffouje SA; Salti GI; Dahdaleh F
    Ann Surg Oncol; 2021 Oct; 28(11):6790-6802. PubMed ID: 33786676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
    Liao YT; Lin YL; Huang J; Hung JS; Lin BR
    Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival.
    Epelboym I; Zenati MS; Hamad A; Steve J; Lee KK; Bahary N; Hogg ME; Zeh HJ; Zureikat AH
    Ann Surg Oncol; 2017 Sep; 24(9):2744-2751. PubMed ID: 28681155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection.
    Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW
    Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival benefit of adjuvant chemotherapy following neoadjuvant therapy and oesophagectomy in oesophageal adenocarcinoma.
    Kamarajah SK; Markar SR; Phillips AW; Kunene V; Fackrell D; Salti GI; Dahdaleh FS; Griffiths EA
    Eur J Surg Oncol; 2022 Sep; 48(9):1980-1987. PubMed ID: 35718676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.